{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:20Z","timestamp":1790787320335,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaip.2018.07.031","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T12:20:27Z","timestamp":1533730827000},"page":"618-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents"],"prefix":"10.1016","volume":"7","author":[{"given":"Ricardo","family":"Madrigal-Burgaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Bernal-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pilar","family":"Berges-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Victoria","family":"Carpio-Escalona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gehlhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Alvarez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.07.031_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaip.2018.07.031_bib2","first-page":"261","article-title":"Acute infusion reactions to chemotherapeutic drugs: a single institute experience","volume":"18","author":"Muallaoglu","year":"2013","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.jaip.2018.07.031_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1756-9966-30-93","article-title":"Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system","volume":"30","author":"Kadoyama","year":"2011","journal-title":"AERS. J Exp Clin Cancer Res"},{"key":"10.1016\/j.jaip.2018.07.031_bib4","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.2174\/1381612822666161025154506","article-title":"Desensitization for drug hypersensitivity to chemotherapy and monoclonal antibodies","volume":"22","author":"Bonamichi-Santos","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaip.2018.07.031_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/all.12620","article-title":"Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization","volume":"70","author":"Alvarez-Cuesta","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaci.2014.09.045","article-title":"Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations","volume":"135","author":"Ure\u00f1a-Tavera","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/all.12105","article-title":"Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment","volume":"68","author":"Madrigal-Burgaleta","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib8","first-page":"435","article-title":"Desensitizing oxaliplatin-induced fever: a case report","volume":"23","author":"Madrigal-Burgaleta","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jaip.2013.12.011","article-title":"Successful rapid desensitization to methylprednisolone sodium hemisuccinate: a case report","volume":"2","author":"Angel-Pereira","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib10","doi-asserted-by":"crossref","unstructured":"Solano-Solares E, Madrigal-Burgaleta R, Carpio-Escalona LV, Bernal-Rubio L, Berges-Gimeno MP, Alvarez-Cuesta E. Chemotherapy in mastocytosis: administration issues, hypersensitivity, and rapid drug desensitization. J Investig Allergol Clin Immunol 2017;27:315-7.","DOI":"10.18176\/jiaci.0171"},{"key":"10.1016\/j.jaip.2018.07.031_bib11","first-page":"1483","article-title":"Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe","volume":"68","author":"Alvarez-Cuesta","year":"2013","journal-title":"Reply. Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib12","series-title":"Hipersensibilidad a los agentes antineopl\u00e1sicos y f\u00e1rmacos biol\u00f3gicos: un nuevo paradigma diagn\u00f3stico y terap\u00e9utico. Doctoral thesis","author":"Madrigal-Burgaleta","year":"2017"},{"key":"10.1016\/j.jaip.2018.07.031_bib13","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaip.2017.11.013","article-title":"Assessment of antihistamines and corticosteroids as premedications in rapid drug desensitization to paclitaxel: outcomes in 155 procedures","volume":"6","author":"Lopez-Gonzalez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jaip.2018.07.031_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.2007.01421.x","article-title":"The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology","volume":"62","author":"Muraro","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00216-009-2939-x","article-title":"Food anaphylaxis","volume":"395","author":"Brockow","year":"2009","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jaip.2018.07.031_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy Organization anaphylaxis guidelines: summary","volume":"127","author":"Simons","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1062860607308146","article-title":"Mistake-proofing in health care: lessons for ongoing patient safety improvements","volume":"22","author":"Clancy","year":"2007","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.jaip.2018.07.031_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1108\/09526860810890431","article-title":"Eliminating US hospital medical errors","volume":"21","author":"Kumar","year":"2008","journal-title":"Int J Health Care Qual Assur"},{"key":"10.1016\/j.jaip.2018.07.031_bib23","first-page":"79","article-title":"Applying Lean Sigma solutions to mistake-proof the chemotherapy preparation process","volume":"36","author":"Aboumatar","year":"2010","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.jaip.2018.07.031_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/cea.12013","article-title":"Value of the clinical history in the diagnosis of urticaria\/angioedema induced by NSAIDs with cross-intolerance","volume":"43","author":"Blanca-Lopez","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014a consensus statement: desensitization for drug hypersensitivity","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)61136-2","article-title":"Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen","volume":"94","author":"Morales","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.iac.2015.01.011","article-title":"Anaphylaxis to chemotherapy and monoclonal antibodies","volume":"35","author":"Castells","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.07.031_bib31","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/eji.201040810","article-title":"Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting Fc\u03b5RI internalization","volume":"41","author":"Sancho-Serra","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1365-2222.2011.03825.x","article-title":"Desensitization regimens for drug allergy: state of the art in the 21st century","volume":"41","author":"Liu","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.07.031_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1081-1206(10)60247-5","article-title":"Acetylsalicylic acid and montelukast block mast cell mediator\u2013related symptoms during rapid desensitization","volume":"102","author":"Breslow","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/14740330903446936","article-title":"Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity","volume":"9","author":"Limsuwan","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2018.07.031_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/eci.11.75","article-title":"Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies","volume":"8","author":"Hong","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaip.2013.08.009","article-title":"Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels","volume":"2","author":"Ojaimi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib37","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaip.2014.04.010","article-title":"Management of hypersensitivity reactions to carboplatin and paclitaxel in an outpatient oncology infusion center: a 5-year review","volume":"2","author":"Banerji","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","article-title":"Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ygyno.2004.11.043","article-title":"Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments","volume":"96","author":"Feldweg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2018.07.031_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ACI.0b013e328355b7e4","article-title":"2012 update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis","volume":"12","author":"Simons","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.07.031_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18176\/jiaci.0031","article-title":"Successful desensitization to cetuximab in a patient with a positive skin test to cetuximab and specific IgE to alpha-gal","volume":"26","author":"Garc\u00eda-Menaya","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2018.07.031_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","article-title":"Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization","volume":"2","author":"Wong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.07.031_bib45","first-page":"537","article-title":"Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin","volume":"34","author":"Pagani","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaip.2018.07.031_bib46","first-page":"354","article-title":"Preventing occupational exposures to antineoplastic drugs in health care settings","volume":"56","author":"Connor","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaip.2018.07.031_bib47","first-page":"26","article-title":"Management of hypersensitivity reactions: a nursing perspective","volume":"23","author":"Viale","year":"2009","journal-title":"Oncol Williston Park N"},{"key":"10.1016\/j.jaip.2018.07.031_bib48","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaip.2016.05.015","article-title":"A\u00a0modified protocol for rapid desensitization to chemotherapy agents","volume":"4","author":"Vidal","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818304689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818304689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:17:06Z","timestamp":1761974226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818304689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213219818304689"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.07.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}